These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 15387340

  • 1. Neurofibromatosis with gastrointestinal stromal tumors: insights into the association.
    Cheng SP, Huang MJ, Yang TL, Tzen CY, Liu CL, Liu TP, Hsiao SC.
    Dig Dis Sci; 2004 Aug; 49(7-8):1165-9. PubMed ID: 15387340
    [Abstract] [Full Text] [Related]

  • 2. Characterization of GIST/GIPACT tumors by inmunohistochemistry and exon 11 analysis of c-kit by PCR.
    Bernet L, Zuñiga A, Cano R.
    Rev Esp Enferm Dig; 2003 Oct; 95(10):688-91, 683-7. PubMed ID: 14588063
    [Abstract] [Full Text] [Related]

  • 3. KIT activation is a ubiquitous feature of gastrointestinal stromal tumors.
    Rubin BP, Singer S, Tsao C, Duensing A, Lux ML, Ruiz R, Hibbard MK, Chen CJ, Xiao S, Tuveson DA, Demetri GD, Fletcher CD, Fletcher JA.
    Cancer Res; 2001 Nov 15; 61(22):8118-21. PubMed ID: 11719439
    [Abstract] [Full Text] [Related]

  • 4. Germline mutation in the juxtamembrane domain of the kit gene in a family with gastrointestinal stromal tumors and urticaria pigmentosa.
    Beghini A, Tibiletti MG, Roversi G, Chiaravalli AM, Serio G, Capella C, Larizza L.
    Cancer; 2001 Aug 01; 92(3):657-62. PubMed ID: 11505412
    [Abstract] [Full Text] [Related]

  • 5. Gastrointestinal stromal tumors with internal tandem duplications in 3' end of KIT juxtamembrane domain occur predominantly in stomach and generally seem to have a favorable course.
    Lasota J, Dansonka-Mieszkowska A, Stachura T, Schneider-Stock R, Kallajoki M, Steigen SE, Sarlomo-Rikala M, Boltze C, Kordek R, Roessner A, Stachura J, Miettinen M.
    Mod Pathol; 2003 Dec 01; 16(12):1257-64. PubMed ID: 14681327
    [Abstract] [Full Text] [Related]

  • 6. Clinicopathological features of gastric stromal tumors.
    Nishida T, Nakamura J, Taniguchi M, Hirota S, Ito T, Kitamura Y, Matsuda H.
    J Exp Clin Cancer Res; 2000 Dec 01; 19(4):417-25. PubMed ID: 11277317
    [Abstract] [Full Text] [Related]

  • 7. Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in gastrointestinal stromal tumors.
    Singer S, Rubin BP, Lux ML, Chen CJ, Demetri GD, Fletcher CD, Fletcher JA.
    J Clin Oncol; 2002 Sep 15; 20(18):3898-905. PubMed ID: 12228211
    [Abstract] [Full Text] [Related]

  • 8. c-kit mutations in gastrointestinal stromal tumors occur preferentially in the spindle rather than in the epithelioid cell variant.
    Wardelmann E, Neidt I, Bierhoff E, Speidel N, Manegold C, Fischer HP, Pfeifer U, Pietsch T.
    Mod Pathol; 2002 Feb 15; 15(2):125-36. PubMed ID: 11850541
    [Abstract] [Full Text] [Related]

  • 9. Absence of c-kit gene mutations in gastrointestinal stromal tumours from neurofibromatosis type 1 patients.
    Kinoshita K, Hirota S, Isozaki K, Ohashi A, Nishida T, Kitamura Y, Shinomura Y, Matsuzawa Y.
    J Pathol; 2004 Jan 15; 202(1):80-5. PubMed ID: 14694524
    [Abstract] [Full Text] [Related]

  • 10. Mutations in exon 11 of the c-kit gene in a myogenic tumor and a neurogenic tumor as well as in gastrointestinal stromal tumors. Utility of c-kit mutation as a prognostic biomarker for gastrointestinal mesenchymal tumor.
    Yasuoka R, Sakakura C, Shimomura K, Fujita Y, Nakanishi M, Aragane H, Hagiwara A, Bamba M, Abe T, Yamagishi H.
    Dig Surg; 2003 Jan 15; 20(3):183-91. PubMed ID: 12759497
    [Abstract] [Full Text] [Related]

  • 11. Intestinal neurofibromatosis is a subtype of familial GIST and results from a dominant activating mutation in PDGFRA.
    de Raedt T, Cools J, Debiec-Rychter M, Brems H, Mentens N, Sciot R, Himpens J, de Wever I, Schöffski P, Marynen P, Legius E.
    Gastroenterology; 2006 Dec 15; 131(6):1907-12. PubMed ID: 17087943
    [Abstract] [Full Text] [Related]

  • 12. Pathology and diagnostic criteria of gastrointestinal stromal tumors (GISTs): a review.
    Miettinen M, Majidi M, Lasota J.
    Eur J Cancer; 2002 Sep 15; 38 Suppl 5():S39-51. PubMed ID: 12528772
    [Abstract] [Full Text] [Related]

  • 13. Detection of c-kit-activating mutations in gastrointestinal stromal tumors by high-resolution amplicon melting analysis.
    Willmore C, Holden JA, Zhou L, Tripp S, Wittwer CT, Layfield LJ.
    Am J Clin Pathol; 2004 Aug 15; 122(2):206-16. PubMed ID: 15323137
    [Abstract] [Full Text] [Related]

  • 14. Gastrointestinal stromal tumors (GISTs): definition, occurrence, pathology, differential diagnosis and molecular genetics.
    Miettinen M, Lasota J.
    Pol J Pathol; 2003 Aug 15; 54(1):3-24. PubMed ID: 12817876
    [Abstract] [Full Text] [Related]

  • 15. Deletion of Trp-557 and Lys-558 in the juxtamembrane domain of the c-kit protooncogene is associated with metastatic behavior of gastrointestinal stromal tumors.
    Wardelmann E, Losen I, Hans V, Neidt I, Speidel N, Bierhoff E, Heinicke T, Pietsch T, Büttner R, Merkelbach-Bruse S.
    Int J Cancer; 2003 Oct 10; 106(6):887-95. PubMed ID: 12918066
    [Abstract] [Full Text] [Related]

  • 16. C-kit gene mutation in human gastrointestinal stromal tumors.
    Hou YY, Tan YS, Sun MH, Wei YK, Xu JF, Lu SH, A-Ke-Su SJ, Zhou YN, Gao F, Zheng AH, Zhang TM, Hou WZ, Wang J, Du X, Zhu XZ.
    World J Gastroenterol; 2004 May 01; 10(9):1310-4. PubMed ID: 15112348
    [Abstract] [Full Text] [Related]

  • 17. Gastrointestinal stromal tumors and leiomyomas in the dog: a histopathologic, immunohistochemical, and molecular genetic study of 50 cases.
    Frost D, Lasota J, Miettinen M.
    Vet Pathol; 2003 Jan 01; 40(1):42-54. PubMed ID: 12627712
    [Abstract] [Full Text] [Related]

  • 18. Familial gastrointestinal stromal tumors, lentigines, and café-au-lait macules associated with germline c-kit mutation treated with imatinib.
    Gupta D, Chandrashekar L, Larizza L, Colombo EA, Fontana L, Gervasini C, Thappa DM, Rajappa M, Rajendiran KS, Sreenath GS, Kate V.
    Int J Dermatol; 2017 Feb 01; 56(2):195-201. PubMed ID: 28074523
    [Abstract] [Full Text] [Related]

  • 19. Low frequency of MAP kinase pathway alterations in KIT and PDGFRA wild-type GISTs.
    Martinho O, Gouveia A, Viana-Pereira M, Silva P, Pimenta A, Reis RM, Lopes JM.
    Histopathology; 2009 Jul 01; 55(1):53-62. PubMed ID: 19614767
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.